Cargando…

Serum LAPTM4B as a Potential Diagnostic and Prognostic Biomarker for Breast Cancer

BACKGROUND: Lysosome-associated protein transmembrane-4 beta (LAPTM4B) is an integral membrane protein overexpressed in various cancers and may function as a prognostic tumor marker. The present study is aimed at understanding the clinical significance of serum LAPTM4B in breast cancer (BC). METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lu, Wang, Yating, Zhang, Qingyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729050/ https://www.ncbi.nlm.nih.gov/pubmed/36506911 http://dx.doi.org/10.1155/2022/6786351

Ejemplares similares

LAPTM4B is a novel diagnostic and prognostic marker for lung adenocarcinoma and associated with mutant EGFR
por: Wang, Lu, et al.
Publicado: (2019)

Increased levels of LAPTM4B, VEGF and survivin are correlated with tumor progression and poor prognosis in breast cancer patients
por: Li, Sha, et al.
Publicado: (2017)

LAPTM4B Gene Expression and Polymorphism as Diagnostic Markers of Breast Cancer in Egyptian Patients
por: Shaker, Olfat, et al.
Publicado: (2015)

AP4 positively regulates LAPTM4B to promote hepatocellular carcinoma growth and metastasis, while reducing chemotherapy sensitivity
por: Meng, Yue, et al.
Publicado: (2018)

LAPTM4B promotes the progression of nasopharyngeal cancer
por: Su, Qun, et al.
Publicado: (2021)

Prognostic Values of LAPTM4B-35 in Human Cancer: A Meta-analysis
por: Zhou, Linghui, et al.
Publicado: (2018)

LAPTM4B Allele *2 Is Associated with Breast Cancer Susceptibility and Prognosis
por: Li, Xiaoyan, et al.
Publicado: (2012)

Relationship Between LAPTM4B Gene Polymorphism and Susceptibility of Malignant Melanoma in Chinese Patients
por: Zhang, Meng, et al.
Publicado: (2014)

LAPTM4B*2 allele is associated with the development of papillary thyroid carcinoma in Chinese women
por: Meng, Yue, et al.
Publicado: (2017)

Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer
por: Li, Yang, et al.
Publicado: (2010)

LAPTM4B facilitates tumor growth and induces autophagy in hepatocellular carcinoma
por: Wang, Fei, et al.
Publicado: (2019)

LAPTM4B: an oncogene in various solid tumors and its functions
por: Meng, Y, et al.
Publicado: (2016)

Relationship between LAPTM4B Gene Polymorphism and Prognosis of Patients following Tumor Resection for Colorectal and Esophageal Cancers
por: Cheng, Xiaojing, et al.
Publicado: (2016)

Transport of LAPTM5 to lysosomes requires association with the ubiquitin ligase Nedd4, but not LAPTM5 ubiquitination
por: Pak, Youngshil, et al.
Publicado: (2006)

Overexpression of LAPTM4B-35: A Novel Marker of Poor Prognosis of Prostate Cancer
por: Zhang, Hongtuan, et al.
Publicado: (2014)

Detection of urinary survivin using a magnetic particles-based chemiluminescence immunoassay for the preliminary diagnosis of bladder cancer and renal cell carcinoma combined with LAPTM4B
por: Yang, Yang, et al.
Publicado: (2018)

LAPTM4B-35 protein is a weak tumor-associated antigen candidate
por: SHI, GUILAN, et al.
Publicado: (2014)

LAPTM4B polymorphism increases susceptibility to multiple cancers in Chinese populations: a meta-analysis
por: Mo, Cuiju, et al.
Publicado: (2014)

LAPTM4B promotes the progression of bladder cancer by stimulating cell proliferation and invasion
por: Yin, Yanhua, et al.
Publicado: (2021)

LAPTM4B-YAP loop feedback amplification enhances the stemness of hepatocellular carcinoma
por: Liao, Jianping, et al.
Publicado: (2023)

Overexpression of LAPTM4B-35 is a negative prognostic factor in head and neck squamous cell carcinoma
por: Kotowski, Ulana, et al.
Publicado: (2019)

LAPTM4B Allele *2 Is a Marker of Poor Prognosis for Gallbladder Carcinoma
por: Zhai, Guojun, et al.
Publicado: (2012)

LAPTM4B gene polymorphism augments the risk of cancer: Evidence from an updated meta‐analysis
por: Hashemi, Mohammad, et al.
Publicado: (2018)

miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression
por: Zhang, Hongtuan, et al.
Publicado: (2015)

Comprehensive bioinformatics analysis identifies LAPTM5 as a potential blood biomarker for hypertensive patients with left ventricular hypertrophy
por: Li, Tiegang, et al.
Publicado: (2022)

Down-regulation of LAPTM5 in human cancer cells
por: Nuylan, Michelle, et al.
Publicado: (2016)

Autophagy-related gene LAPTM4B promotes the progression of renal clear cell carcinoma and is associated with immunity
por: Wang, He, et al.
Publicado: (2023)

The relationship between LAPTM4B polymorphisms and cancer risk in Chinese Han population: a meta-analysis
por: Xia, Ling-Zi, et al.
Publicado: (2015)

LAPTM4B knockdown increases the radiosensitivity of EGFR-overexpressing radioresistant nasopharyngeal cancer cells by inhibiting autophagy
por: Chu, Chu, et al.
Publicado: (2019)

Association between LAPTM4B gene polymorphism and susceptibility to and prognosis of diffuse large B-cell lymphoma
por: Ding, Huirong, et al.
Publicado: (2018)

Long Non-Coding RNAs as Potential Diagnostic and Prognostic Biomarkers in Breast Cancer: Progress and Prospects
por: Lu, Cuicui, et al.
Publicado: (2021)

A Role for the Ubiquitin Ligase Nedd4 in Membrane Sorting of LAPTM4 Proteins
por: Milkereit, Ruth, et al.
Publicado: (2011)

Long Noncoding RNA HCAL Facilitates the Growth and Metastasis of Hepatocellular Carcinoma by Acting as a ceRNA of LAPTM4B
por: Xie, Cheng-Rong, et al.
Publicado: (2017)

LAPTM4B-35, a Cancer-Related Gene, Is Associated with Poor Prognosis in TNM Stages I-III Gastric Cancer Patients
por: Cheng, Xiaojing, et al.
Publicado: (2015)

LAPTM4B‐35 promotes cancer cell migration via stimulating integrin beta1 recycling and focal adhesion dynamics
por: Liu, Minxia, et al.
Publicado: (2022)

Targeting a novel cancer-driving protein (LAPTM4B-35) by a small molecule (ETS) to inhibit cancer growth and metastasis
por: Li, Maojin, et al.
Publicado: (2016)

Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer
por: Kong, Fanming, et al.
Publicado: (2016)

Serum semaphorin4C as an auxiliary diagnostic biomarker for breast cancer
por: Wang, Ya, et al.
Publicado: (2021)

Serum Lipidomic Profiling in Breast Cancer to Identify Screening, Diagnostic, and Prognostic Biomarkers
por: Fichtali, Karima, et al.
Publicado: (2020)

Co-expression of HIF-1α, MDR1 and LAPTM4B in peripheral blood of solid tumors
por: Rehman, Zaira, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ceseki9ai7e7c8sp4cf8anmnd0